You just read:

AbbVie's HUMIRA® (Adalimumab) Receives CHMP Positive Opinion to Treat Adolescents with Hidradenitis Suppurativa, a Chronic Inflammatory Skin Disease

News provided by

AbbVie

Nov 14, 2016, 03:00 ET